##plugins.themes.academic_pro.article.main##
Abstract
The clinical pharmacological approach to antibacterial therapy in older people is crucial for ensuring effective treatment while minimizing adverse effects and resistance development. This article explores age-related physiological changes that influence drug pharmacokinetics and pharmacodynamics, including altered absorption, distribution, metabolism, and excretion. The selection of appropriate antibacterial agents, dose adjustments, drug interactions, and the risks of polypharmacy in elderly patients are analyzed. Additionally, strategies for optimizing therapy to reduce antibiotic resistance and improve patient outcomes are discussed, along with recent advancements in geriatric antimicrobial stewardship
Keywords
##plugins.themes.academic_pro.article.details##
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
References
- Nicolle LE. Antimicrobial resistance in the elderly: issues and solutions. Clin Geriatr Med.
- ;32(2):295-311.
- Lodise TP, Rodvold KA. Issues in the pharmacokinetics and pharmacodynamics of anti-infective
- agents in older patients. Drugs Aging. 2006;23(6):475-490.
- Falcone M, Paul M, Yahav D, et al. Antimicrobial stewardship in the elderly: the importance of
- considering age-related changes. Clin Microbiol Infect. 2019;25(8):907-915.
- Piddock LJV. The crisis of antimicrobial resistance: what can we do now and in the future? BMJ.
- ;344:e3469.
- Gudiol C, Cuervo G, Carratalà J. Optimizing antibiotic use in older adults with bacterial infections.
- Expert Rev Anti Infect Ther. 2018;16(2):95-105.